US FDA May Scrap Clinical Study Report Disclosure For New Drug Approvals

 
• By Derrick Gingery
  
FDA entrance sign 2016
The FDA may shift its focus on improving approval transparency to the integrated review document template instead. • Source: File photo

More from Product Reviews

More from Pink Sheet